MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/clinem/dgad001

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2023

Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes.

Alhamar Ghadeer, Briganti Silvia, Maggi Daria, Viola Viola, Faraj Malak, Zannella Carla, Galdiero Massimiliano, Franci Gianluigi, Fusco Clorinda, Isgrò Camilla, Leanza Giulia, Malandrucco Ilaria, Spinelli Andrea, Tramontana Flavia, Iaria Domenico, Tortoriello Rachele, Pieralice Silvia, Rosati Milena, Matarese Giuseppe, Pozzilli Paolo, Galgani Mario, Strollo Rocky

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

CONTEXT: Poor glucose control has been associated with increased mortality in COVID-19 patients with type 1 diabetes (T1D).

OBJECTIVE

This work aimed to assess the effect of prevaccination glucose control on antibody response to the SARS-CoV-2 vaccine BNT162b2 in T1D.

METHODS

We studied 26 patients with T1D scheduled to receive 2 doses, 21 days apart, of BNT162b2, followed prospectively for 6 months with regular evaluation of SARS-CoV-2 antibodies and glucose control. Immunoglobulin G (IgG) to spike glycoprotein were assessed by enzyme-linked immunosorbent assay, and serum neutralization by a live SARS-CoV-2 assay (Vero E6 cells system). Glycated hemoglobin A1c (HbA1c) and continuous glucose monitoring (CGM), including time in range (TIR) and above range (TAR), were collected. The primary exposure and outcome measures were prevaccination glucose control, and antibody response after vaccination, respectively.

RESULTS

Prevaccination HbA1c was unrelated to postvaccine spike IgG (r = -0.33; P = .14). Of note, the CGM profile collected during the 2 weeks preceding BNT162b2 administration correlated with postvaccine IgG response (TIR: r = 0.75; P = .02; TAR: r = -0.81; P = .008). Patients meeting the recommended prevaccination glucose targets of TIR (≥ 70%) and TAR (≤ 25%) developed stronger neutralizing antibody titers (P < .0001 and P = .008, respectively), regardless of HbA1c. Glucose control along the study time frame was also associated with IgG response during follow-up (TIR: r = 0.93; P < .0001; TAR: r = -0.84; P < .0001).

CONCLUSION

In T1D, glucose profile during the 2 weeks preceding vaccination is associated with stronger spike antibody binding and neutralization, highlighting a role for well-controlled blood glucose in vaccination efficacy.

Для цитирования: Alhamar Ghadeer, Briganti Silvia, Maggi Daria, Viola Viola, Faraj Malak, Zannella Carla, Galdiero Massimiliano, Franci Gianluigi, Fusco Clorinda, Isgrò Camilla, Leanza Giulia, Malandrucco Ilaria, Spinelli Andrea, Tramontana Flavia, Iaria Domenico, Tortoriello Rachele, Pieralice Silvia, Rosati Milena, Matarese Giuseppe, Pozzilli Paolo, Galgani Mario, Strollo Rocky. Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes.. The Journal of clinical endocrinology and metabolism. 2023. DOI: 10.1210/clinem/dgad001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.